Aleksandra Antovič

1.3k total citations
73 papers, 991 citations indexed

About

Aleksandra Antovič is a scholar working on Hematology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aleksandra Antovič has authored 73 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 26 papers in Rheumatology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aleksandra Antovič's work include Blood Coagulation and Thrombosis Mechanisms (21 papers), Systemic Lupus Erythematosus Research (18 papers) and Platelet Disorders and Treatments (16 papers). Aleksandra Antovič is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (21 papers), Systemic Lupus Erythematosus Research (18 papers) and Platelet Disorders and Treatments (16 papers). Aleksandra Antovič collaborates with scholars based in Sweden, Serbia and United States. Aleksandra Antovič's co-authors include Jovan P. Antović, Shu He, Fariborz Mobarrez, Håkan Wallén, Elisabet Svenungsson, Katarina Bremme, Gun Jörneskog, Margareta Blombäck, Maria Bruzelius and Margareta Holmström and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Aleksandra Antovič

69 papers receiving 965 citations

Peers

Aleksandra Antovič
Aleksandra Antovič
Citations per year, relative to Aleksandra Antovič Aleksandra Antovič (= 1×) peers Neta Goldschmidt

Countries citing papers authored by Aleksandra Antovič

Since Specialization
Citations

This map shows the geographic impact of Aleksandra Antovič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksandra Antovič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksandra Antovič more than expected).

Fields of papers citing papers by Aleksandra Antovič

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksandra Antovič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksandra Antovič. The network helps show where Aleksandra Antovič may publish in the future.

Co-authorship network of co-authors of Aleksandra Antovič

This figure shows the co-authorship network connecting the top 25 collaborators of Aleksandra Antovič. A scholar is included among the top collaborators of Aleksandra Antovič based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksandra Antovič. Aleksandra Antovič is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Vedder, Daisy, Anna Rudin, Dan Nordström, et al.. (2024). Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study. RMD Open. 10(4). e004838–e004838.
3.
Hansson, Monika, Linda Mathsson‐Alm, Vijay Joshua, et al.. (2024). Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis—a prospective cohort study. Lara D. Veeken. 63(11). 3164–3171. 7 indexed citations
4.
Antović, Jovan P., et al.. (2024). The role of complement and extracellular vesicles in the development of pulmonary embolism in severe COVID-19 cases. PLoS ONE. 19(8). e0309112–e0309112. 1 indexed citations
5.
Taxiarchis, Apostolos, Bo‐Michael Bellander, Jovan P. Antović, et al.. (2023). Extracellular vesicles in plasma and cerebrospinal fluid in patients with COVID‐19 and neurological symptoms. International Journal of Laboratory Hematology. 46(1). 42–49. 5 indexed citations
6.
Hansson, Monika, Linda Mathsson‐Alm, Vijay Joshua, et al.. (2023). OP0120 IDENTIFICATION OF EARLY RISK FACTORS IN A NOVEL PREDICTION MODEL FOR ACPA POSITIVE RA. Annals of the Rheumatic Diseases. 82. 78–79. 1 indexed citations
8.
Vojinović, Jelena, Annica Nordin, Annette Bruchfeld, et al.. (2023). Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides. Frontiers in Medicine. 10. 1240325–1240325. 3 indexed citations
9.
Kits, Annika, et al.. (2022). Fatal Acute Hemorrhagic Encephalomyelitis and Antiphospholipid Antibodies following SARS-CoV-2 Vaccination: A Case Report. Vaccines. 10(12). 2046–2046. 5 indexed citations
10.
Stojanović, Aleksandra, Mirjana Veselinović, Nevena Draginić, et al.. (2021). The Influence of Menopause and Inflammation on Redox Status and Bone Mineral Density in Patients with Rheumatoid Arthritis. Oxidative Medicine and Cellular Longevity. 2021(1). 9458587–9458587. 7 indexed citations
11.
Vojinović, Jelena, Annica Nordin, Annette Bruchfeld, et al.. (2020). Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV). Journal of Molecular Medicine. 98(9). 1279–1286. 14 indexed citations
12.
Antovič, Aleksandra, Fariborz Mobarrez, Annica Nordin, et al.. (2019). Microparticles Expressing Myeloperoxidase and Complement C3a and C5a as Markers of Renal Involvement in Antineutrophil Cytoplasmic Antibody–associated Vasculitis. The Journal of Rheumatology. 47(5). 714–721. 19 indexed citations
13.
Antovič, Aleksandra, Maria Berndtsson, Agnes Rasmuson, et al.. (2017). Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting. Thrombosis and Haemostasis. 117(9). 1700–1704. 37 indexed citations
14.
Svenungsson, Elisabet, Anna Ågren, Fariborz Mobarrez, et al.. (2014). Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome. Thrombosis Research. 133(5). 936–944. 20 indexed citations
15.
Mobarrez, Fariborz, Shu He, Anders Bröijersén, et al.. (2011). Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thrombosis and Haemostasis. 106(8). 344–352. 83 indexed citations
16.
Tehrani, Sara, Fariborz Mobarrez, Aleksandra Antovič, et al.. (2010). Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Thrombosis Research. 126(3). e225–e231. 52 indexed citations
17.
He, Shu, et al.. (2005). Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials. Blood Coagulation & Fibrinolysis. 16(1). 61–67. 30 indexed citations
18.
Antovič, Aleksandra, et al.. (2005). Marked increase of fibrin gel permeability with very low dose ASA treatment. Thrombosis Research. 116(6). 509–517. 41 indexed citations
19.
Antović, Jovan P., Marianne Yngen, Aleksandra Antovič, et al.. (2003). Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications. Blood Coagulation & Fibrinolysis. 14(6). 551–556. 22 indexed citations
20.
Antovič, Aleksandra, Margareta Blombäck, Katarina Bremme, & Shu He. (2002). The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism. Blood Coagulation & Fibrinolysis. 13(3). 181–186. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026